Related Experiment Video
Updated: Sep 26, 2025
06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.6K
Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis
Taiqin Chen1, Ki-Yeol Kim2, Yeongjoo Oh3
1Department of Dermatology, Yanbian University Hospital, Yanji 133000, China.
Cancers
|April 23, 2022
Summary
Coatomer protein complex subunit beta 2 (COPB2) is elevated in cutaneous squamous cell carcinoma (cSCC), correlating with poor survival and immune microenvironment markers. COPB2 knockdown inhibits cSCC progression, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The molecular mechanisms driving cutaneous squamous cell carcinoma (cSCC) remain poorly understood.
- Coatomer protein complex subunit beta 2 (COPB2) has emerged as a potential factor in cancer development.
Purpose of the Study:
- To investigate the role of COPB2 expression in cSCC pathogenesis.
- To evaluate COPB2 as a prognostic biomarker and potential therapeutic target in cSCC.
Main Methods:
- Analysis of the Gene Expression Omnibus (GEO) database and a retrospective cohort of 95 cSCC patients.
- In vitro and in vivo experiments assessing the biological behavior of cSCC cells following COPB2 knockdown.
Main Results:
- COPB2 expression was significantly higher in cSCC tissues compared to normal skin.
- COPB2 levels correlated with tumor immune microenvironment indicators (MHC I, MHC II, CD4+/CD8+ TILs) and predicted worse recurrence-free survival.
- COPB2 knockdown reduced cSCC cell proliferation, invasion, and tumorigenicity while increasing apoptosis.
Conclusions:
- COPB2 is upregulated in cSCC and associated with a poorer prognosis and altered tumor immune microenvironment.
- COPB2 functions as a potential oncogene in cSCC.
- COPB2 represents a promising predictive biomarker and immunotherapeutic target for cSCC.
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Related Concept Videos
01:30Skin Cancer
4.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.7K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
01:31The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.2K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K